Immuno-fluorescence in situ hybridization index predicts survival in patients with diffuse large B-cell lymphoma treated with R-CHOP: a GELA study. [electronic resource]
Producer: 20100105Description: 5573-9 p. digitalISSN:- 1527-7755
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Murine-Derived
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Biomarkers -- blood
- Cyclophosphamide
- Dose-Response Relationship, Drug
- Doxorubicin
- Drug Administration Schedule
- Enzyme-Linked Immunosorbent Assay
- Female
- Genes, myc
- Humans
- In Situ Hybridization, Fluorescence
- Lymphoma, Large B-Cell, Diffuse -- drug therapy
- Male
- Middle Aged
- Multivariate Analysis
- Predictive Value of Tests
- Prednisone
- Probability
- Prognosis
- Proportional Hazards Models
- Proto-Oncogene Proteins c-bcl-2 -- analysis
- Risk Assessment
- Rituximab
- Severity of Illness Index
- Survival Analysis
- Treatment Outcome
- Vincristine
No physical items for this record
Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.